New dual therapy may simplify h. pylori treatment without losing effectiveness
NCT ID NCT06412588
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a two-drug combination (vonoprazan plus either amoxicillin or doxycycline) works as well as the standard four-drug bismuth quadruple therapy for eradicating H. pylori infection. 579 adults with H. pylori took one of three 14-day treatments. Researchers measured eradication rates, side effects, and how well patients followed the regimen. The goal is to find a simpler, safer, and more affordable treatment option.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HELICOBACTER PYLORI INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
NanJing Frist Hospital
Nanjing, Jiangsu, 210006, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a fecal transplant beat a stubborn stomach bug?
- AI eye on stomach cancer: 6,000-Person trial tests smarter scopes
- Simpler h. pylori treatment could reduce antibiotic use
- AI to predict cancer risk from gut bacteria and scans
- Stool test could replace endoscopy for h. pylori treatment decisions
- New hope against stomach bug in Antibiotic-Resistant region